Cryptic natural autoantibodies and co-potentiators

被引:30
作者
Cheng, H. M. [1 ]
Chamley, L. [2 ]
机构
[1] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur 50603, Malaysia
[2] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand
关键词
natural; cryptic; unmasked; autoantibodies;
D O I
10.1016/j.autrev.2008.03.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural autoantibodies are normal components of the Immoral arm of the immune system found in clinically healthy individuals. There are two subpopulations of natural antibodies, including an overt group of antibodies that are readily detected in unfractionated normal human sera. The other natural antibody subgroup is revealed by physico or biochemical treatment of normal human sera in vitro. Unmasking of this latter cryptic natural autoantibodies (cNA) may occur in vivo by local factors in the tissue environment of disease states. The masking cryptic factors may be immunoglobulin (Ig) or non-Ig in nature. These factors may either be co-inhibitors or co-enhancers of cNA. In the heat-potentiated binding of natural anti-phospholipid antibodies, apolipoprotein H (beta 2-glycoprotein 1) appears to act as a co-enhancer. The immumo-relationship between the in vitro and in vivo cNA phenomenon remains to be elucidated. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:431 / 434
页数:4
相关论文
共 39 条
[11]  
Cabiedes J, 1998, EUR J IMMUNOL, V28, P2108, DOI 10.1002/(SICI)1521-4141(199807)28:07<2108::AID-IMMU2108>3.3.CO
[12]  
2-I
[13]  
Chamley LW, 1999, CLIN EXP IMMUNOL, V115, P571
[14]   CRYPTIC ANTIPHOSPHOLIPID AUTOANTIBODIES AND SERUM CO-INHIBITORS [J].
CHENG, HM .
AUTOIMMUNITY, 1994, 19 (02) :127-133
[15]  
CHENG HM, 1988, J IMMUNOL METHODS, V114, P279
[16]   Natural cryptic autoantibodies [J].
Cheng, HM .
AUTOIMMUNITY, 1998, 27 (02) :99-108
[17]   Natural antibodies and blood pressure hormones [J].
Cheng, HM ;
Aafaqi, S ;
Sam, CK .
AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (05) :569-570
[18]  
Cheng HM, 2000, AUT AUT AUTOANTIBOD, V1, P397
[19]  
CHENG HM, 1999, PATHOGENIC DIAGNOSTI, P135
[20]  
Cheng HW, 1994, IMMUNOPHYSIOLOGY ANT